Rights & Society
EMA Boosts Efforts for Medicines on Women's Health
The European Medicines Agency (EMA) is launching a series of new initiatives to better integrate women's health needs into the development and regulation of medicines. This move aims to address historical gaps in research and ensure that treatments are safe and effective for conditions that uniquely or disproportionately affect women. The agency will work to improve data collection on gender-specific factors in clinical trials and raise awareness among drug developers. These efforts are part of a broader strategy to advance public health by ensuring medicines meet the needs of all patient populations.
The EU is taking action to ensure new medicines are better tailored to women's specific health needs.